• Issue

    Journal of Viral Hepatitis: Volume 28, Issue 4

    579-690
    April 2021
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 579-581
  • First Published: 10 March 2021

ORIGINAL ARTICLES

Adherence to pregnancy hepatitis B care guidelines in women and infants in the United States and evaluation of two interventions to improve care: A multicentre hospital-based study

Tatyana Kushner,  Elianna Kaplowitz,  Rena Mei,  Chelsea Xu,  Alex Acker,  Emma Rosenbluth,  Igbagbosanmi Oredein,  Monika Sarkar,  Norah Terrault,  Meena Bansal,  Kimberly A. Forde, 
  • Pages: 582-591
  • First Published: 29 December 2020

The 48-week safety and therapeutic effects of tenofovir alafenamide in hbv-related acute-on-chronic liver failure: A prospective cohort study

Yeqiong Zhang,  Wenxiong Xu,  Xiang Zhu,  Xuejun Li,  Jianguo Li,  Xin Shu,  Jing Lai,  Junqiang Xie,  Chan Xie,  Liang Peng, 
  • Pages: 592-600
  • First Published: 10 January 2021
Open Access

Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta-analysis

Aixin Song,  Xiaoxiao Wang,  Junfeng Lu,  Yi Jin,  Lina Ma,  Zhongjie Hu,  Yanhong Zheng,  Chengli Shen,  Xinyue Chen, 
  • Pages: 601-612
  • First Published: 17 January 2021

Impact of maternal infection with hepatitis B virus on pregnancy complications and neonatal outcomes for women undergoing assisted reproductive technology treatment: A population-based study

Yiquan Xiong,  Chunrong Liu,  Shiyao Huang,  Jing Wang,  Yana Qi,  Guanhua Yao,  Wei Sun,  Yongyao Qian,  Lishan Ye,  Hui Liu,  Qiushi Xu,  Kang Zou,  Jing Tan,  Xin Sun, 
  • Pages: 613-620
  • First Published: 16 January 2021

Mortality in relation to hepatitis B virus (HBV) infection status among HIV-HBV co-infected patients in sub-Saharan Africa after immediate initiation of antiretroviral therapy

Amir M. Mohareb,  Gérard Menan Kouamé,  Audrey Gabassi,  Delphine Gabillard,  Raoul Moh,  Anani Badje,  Arlette Emième,  Sarah Maylin,  Hervé Ménan,  Emily P. Hyle,  Constance Delaugerre,  Christine Danel,  Xavier Anglaret,  Karine Lacombe,  Serge P. Eholié,  Anders Boyd, 
  • Pages: 621-629
  • First Published: 31 December 2020

Proton pump inhibitor usage reduces sustained viral response rates for veterans with HIV/HCV coinfection on ledipasvir/sofosbuvir: a real-world study from a multicentre VA cohort

Tzu-Hao Lee,  Austin Chan,  William Bryan,  Lawrence Park,  Mohamed Hashem,  Mary Townsend,  Cynthia Moylan,  Rachel Britt,  Steve Choi,  Susanna Naggie, 
  • Pages: 630-636
  • First Published: 30 December 2020

Improvement in cognitive impairment following a 12-week aerobic exercise intervention in individuals with non-cirrhotic chronic hepatitis C

Philip O’Gorman,  Orla Strahan,  Damien Ferguson,  Ann Monaghan,  Megan Kennedy,  Cuisle Forde,  Ashanty M. Melo,  Derek G. Doherty,  Kelly K. O’Brien,  Susan McKiernan,  Rose Anne Kenny,  Robert Coen,  Colin Doherty,  Colm Bergin,  John Gormley,  Suzanne Norris, 
  • Pages: 637-650
  • First Published: 28 December 2020

Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project

Francesca Romana Ponziani,  Francesco Santopaolo,  Massimo Siciliano,  Antonio Giulio De Belvis,  Annalisa Tortora,  Vincenzina Mora,  Caterina Fanali,  Alisha Morsella,  Fulvio Balducci,  Giuseppe Vetrugno,  Maria Elena D’Alfonso,  Andrea Cambieri,  Roberto Cauda,  Rocco Bellantone,  Maurizio Sanguinetti,  Maurizio Pompili,  Antonio Gasbarrini, 
  • Pages: 651-656
  • First Published: 09 January 2021

Evaluation of seven rapid diagnostic tests for detection of hepatitis C virus antibodies in China

Bing Chen,  Zhong-Hui Ma,  Bing Xu,  Hao Chang,  Xiao-Xia He,  Li-Jian Pei,  Ya-Nan Ren,  Wen-Ge Xing, 
  • Pages: 657-663
  • First Published: 09 January 2021

Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta-analysis

Xin Su,  Xin Zhao,  Jia-Long Deng,  Song-Nan Li,  Xin Du,  Jian-Zeng Dong,  Chang-Sheng Ma, 
  • Pages: 664-671
  • First Published: 16 January 2021

Hepatitis E-Associated Hospitalizations in the United States: 2010–2015 and 2015–2017

Paul Wasuwanich,  Thammasin Ingviya,  Supharerk Thawillarp,  Eyasu H. Teshale,  Saleem Kamili,  Jude P. Crino,  Ann O. Scheimann,  Cynthia Argani,  Wikrom Karnsakul, 
  • Pages: 672-681
  • First Published: 11 December 2020

SHORT COMMUNICATION

Risk factors for difficult-to-treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub-Saharan Africa

Fabienne Shumbusho,  Anne F. Liu,  Fredrick Kateera,  Jules Kabahizi,  Sabin Nsanzaimana,  Janvier Serumondo,  Jean Damascene Makuza,  Philip M. Grant,  Emmanuel Musabeyezu,  Claude Muvunyi,  Neil Gupta, 
  • Pages: 682-686
  • First Published: 09 January 2021

LETTERS TO THE EDITOR

Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action-more detailed kinetic studies are needed

Harel Dahari,  Amir Shlomai,  Scott J. Cotler, 
  • Pages: 687-688
  • First Published: 01 January 2021

Reply to: ‘Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action’

Antonio Gonçalves,  Annabelle Lemenuel-Diot,  Jérémie Guedj, 
  • Pages: 689-690
  • First Published: 18 January 2021